Neovasc Inc (NVCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NVCN | TMO | ISRG | EW | DXCM |
| Company | Neovasc Inc | Thermo Fisher Scientific Inc | Intuitive Surg Inc | Edwards Lifesciences Corp | Dexcom Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 29.59 | 538.65 | 437.94 | 91.24 | 111.17 |
| High | 30.07 | 540.17 | 445.05 | 92.45 | 113.83 |
| Low | 29.43 | 533.85 | 433.44 | 90.62 | 110.03 |
| Last | 30.03 | 540.10 | 443.76 | 92.32 | 113.69 |
| Change | +0.49 | +4.49 | +8.95 | +1.24 | +2.78 |
| % Change | +1.66% | +0.84% | +2.06% | +1.36% | +2.51% |
| Volume | 45,401 | 1,233,200 | 1,114,500 | 1,515,100 | 1,347,200 |
| 20-Day Average Volume | 26,715 | 1,780,190 | 1,459,650 | 3,119,365 | 2,908,960 |
| Previous Close | 29.54 | 535.61 | 434.81 | 91.08 | 110.91 |
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 29.47 | 561.67 | 431.86 | 89.51 | 114.45 |
| 20-Day Raw Stochastic | 96.12% | 14.32% | 89.91% | 81.17% | 49.36% |
| 20-Day Relative Strength | 66.89% | 36.19% | 65.77% | 58.28% | 42.36% |
| Weighted Alpha | +325.80 | +3.34 | +43.73 | +11.49 | -8.36 |
| Today's Opinion | 100% Buy | 8% Sell | 100% Buy | 88% Buy | 72% Sell |
| Previous Opinion | 100% Buy | 24% Sell | 100% Buy | 88% Buy | 72% Sell |
| Last Month's Opinion | 100% Buy | 56% Buy | 100% Buy | 48% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.02% since 03/31/23 | -1.94% since 06/27/24 | -0.30% since 06/27/24 | -1.09% since 06/27/24 | -0.74% since 06/27/24 |
| Low | 29.09 on 04/05/23 | 532.43 on 07/03/24 | 432.20 on 07/02/24 | 89.80 on 07/02/24 | 109.81 on 07/03/24 |
| High | 30.07 on 04/10/23 | 558.27 on 06/28/24 | 448.10 on 07/01/24 | 93.99 on 06/28/24 | 115.29 on 07/01/24 |
| 1-Month | |||||
| %Chg | +3.41% since 03/10/23 | -6.12% since 06/05/24 | +6.36% since 06/05/24 | +6.03% since 06/05/24 | -3.72% since 06/05/24 |
| Low | 29.04 on 03/16/23 | 532.43 on 07/03/24 | 405.08 on 06/06/24 | 85.12 on 06/17/24 | 108.71 on 06/25/24 |
| High | 30.07 on 04/10/23 | 585.95 on 06/07/24 | 448.10 on 07/01/24 | 93.99 on 06/28/24 | 118.80 on 06/12/24 |
| 3-Month | |||||
| %Chg | +62.50% since 01/10/23 | -6.79% since 04/05/24 | +14.26% since 04/05/24 | -0.41% since 04/05/24 | -18.17% since 04/05/24 |
| Low | 18.18 on 01/11/23 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 83.50 on 05/01/24 | 108.71 on 06/25/24 |
| High | 30.07 on 04/10/23 | 602.00 on 05/15/24 | 448.10 on 07/01/24 | 93.99 on 06/28/24 | 141.99 on 04/09/24 |
| 6-Month | |||||
| %Chg | +361.29% since 10/10/22 | +1.67% since 01/05/24 | +37.60% since 01/05/24 | +26.73% since 01/05/24 | -8.30% since 01/05/24 |
| Low | 6.38 on 10/12/22 | 527.40 on 01/08/24 | 324.12 on 01/08/24 | 71.92 on 01/25/24 | 108.71 on 06/25/24 |
| High | 30.07 on 04/10/23 | 603.82 on 03/08/24 | 448.10 on 07/01/24 | 96.12 on 03/28/24 | 142.00 on 03/26/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 82,375 | 206,164,800 | 157,401,680 | 55,632,032 | 45,212,696 |
| Shares Outstanding, K | 2,743 | 381,716 | 354,700 | 602,600 | 397,684 |
| Annual Sales | 3,810,000 | 42,857,000,000 | 7,124,100,000 | 6,004,800,000 | 3,622,300,000 |
| Annual Net Income | -41,200,000 | 5,995,000,000 | 1,798,000,000 | 1,402,400,000 | 541,500,000 |
| Last Quarter Sales | 1,450,000 | 10,345,000,000 | 1,890,600,000 | 1,598,200,000 | 921,000,000 |
| Last Quarter Net Income | -13,840,000 | 1,327,000,000 | 544,900,000 | 351,900,000 | 146,400,000 |
| 60-Month Beta | 1.70 | 0.77 | 1.39 | 1.11 | 1.16 |
| Per-Share Information | |||||
| Most Recent Earnings | -5.04 on 03/31/23 | 5.11 on 04/24/24 | 1.50 on 04/18/24 | 0.66 on 04/25/24 | 0.32 on 04/25/24 |
| Latest Earnings Date | 05/11/23 | 07/24/24 | 07/18/24 | 07/24/24 | 07/25/24 |
| Most Recent Dividend | N/A | 0.390 on 06/14/24 | N/A | N/A | N/A |
| Next Ex-Dividends Date | N/A | 06/14/24 | N/A | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 24.77 | 92.91 | 35.72 | 66.81 |